Objetivo: avaliar os efeitos de vídeo educativo sobre o conhecimento, a atitude e a prática de gestantes para o parto ativo. Métodos: estudo quase experimental, desenvolvido em dez unidades básicas de saúde da família, com 167 gestantes no último trimestre, por meio de instrumento construído e validado para levantamento do conhecimento, da atitude e prática. No Grupo Intervenção, a investigação foi aplicada, acompanhada de sessão educativa, com exposição de vídeo. Para o Grupo Controle, a investigação e a consulta pré-natal de rotina foram aplicadas. Resultados: o Grupo Intervenção apresentou maior adequação em conhecimento, atitude e prática, com estatísticas significativas em todas as variáveis, destacando a influência do vídeo educativo para o parto ativo. Conclusão: o uso de vídeo educativo se destacou positivamente como tecnologia educacional para conhecimento, atitude e prática de gestantes em relação ao parto ativo.

Objective: to report the experience of a health team in restructuring service at a mastology outpatient clinic. Methods: an experience report in a public university service mastology outpatient in Ceará between March and April 2020. Service in this outpatient clinic is exclusively for women and who have breast changes for surgical treatments ranging from nodulectomies to mastectomies with oncoplastic. Results: increased COVID-19 cases brought the need to restructure healthcare services. The following steps were followed: identification of scheduled patients, reading of clinical developments in electronic medical records, individual assessment to define whether or not appointment would remain, telephone contact to inform about unscheduling. Among the 555 consultations scheduled for March and April 2020, 316 (56.9%) were maintained. Final considerations: restructuring consultations at a mastology outpatient clinic optimized the waiting time for consultations and avoided crowds at service, providing patient safety.

Capítulo 4: Segurança do paciente: Indicadores de qualidade da assistência de enfermagem no pós-operatório de cirurgia cardíaca pediátrica ..

Capítulo 4: Segurança do paciente: Indicadores de qualidade da assistência de enfermagem no pós-operatório de cirurgia cardíaca pediátrica ..

Objective To map the evidence available in the literature on the health-related quality of life of women with breast cancer using hormone therapy. Data sources This review followed the Joanna Briggs Institute methodological recommendations and Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews reporting guidelines. Searches were performed in nine databases using descriptors, synonyms and keywords; grey literature was also included. The review protocol was registered with the Open Science Framework under doi: http://doi.org/10.17605/OSF.IO/347FM . Inclusion criteria were established according to the Population, Concept, and Context strategy. The selection of studies was performed by two independent reviewers with the aid of RAYYAN software and disagreements were resolved by a third reviewer. The main information from the included articles was grouped into textual categories and presented by means of a narrative synthesis. Data Summary A total of 5419 records were identified, of which 42 studies fully met the eligibility criteria. Most were multicenter studies (42.9%) and randomized controlled trials (62%). Most studies addressed anastrozole (39.5%), letrozole (34.2%), and tamoxifen (26.3%), which were studied alone or in combination. The most widely used health-related quality-of-life assessment tool was the EORTC-QLQ-C30. The concomitant use of hormone therapy and cyclin-dependent kinase inhibitors 4 and 6 showed improvement in health-related quality of life. Conclusion In recent years there has been an increase in studies focused on health-related quality of life, and the evidence pointed to relevant information on health-related quality of life and the use of endocrine therapy, tamoxifen in combination with aromatase inhibitors, as well as aromatase inhibitor alone and the use of cyclin-dependent kinase 4 and 6.